Residential exposure to Aspergillus spp. is associated with exacerbations in COPD
Sensitisation to is linked to worse outcomes in patients with chronic obstructive pulmonary disease (COPD), however, its prevalence and clinical implications in domestic (residential) settings remains unknown. Individuals with COPD (n=43) recruited in Singapore had their residences prospectively sam...
Saved in:
Published in | The European respiratory journal p. 2400907 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
10.10.2024
|
Online Access | Get full text |
Cover
Loading…
Abstract | Sensitisation to
is linked to worse outcomes in patients with chronic obstructive pulmonary disease (COPD), however, its prevalence and clinical implications in domestic (residential) settings remains unknown.
Individuals with COPD (n=43) recruited in Singapore had their residences prospectively sampled and assessed by shotgun metagenomic sequencing including indoor air, outdoor air, and touch surfaces (total: 126 specimens). The abundance of environmental
and the occurrence of
(Asp f) allergens in the environment were determined and immunological responses to
allergens determined in association with clinical outcomes including exacerbation frequency. Findings were validated in 12 individuals (31 specimens) with COPD in Vancouver, Canada, a climatically different region.
157 metagenomes from 43 homes were assessed. Eleven and nine separate
were identified in Singapore and Vancouver respectively. Despite climatic, temperature, and humidity variation,
was detectable in the environment from both locations. The relative abundance of environmental
was significantly associated with exacerbation frequency in both Singapore (r=0.27, p=0.003) and Vancouver (r=0.49, p=0.01) and individuals with higher Asp f 3 sensitisation responses lived in homes with a greater abundance of environmental Asp f 3 allergens (p=0.037). Patients exposed and sensitised to Asp f 3 allergens demonstrated a higher rate of COPD exacerbations at 1-year follow-up (p=0.021).
Environmental
exposure in the home environment including air and surfaces with resulting sensitisation carries pathogenic potential in individuals with COPD. Targeting domestic
abundance may reduce COPD exacerbations. |
---|---|
AbstractList | Background Sensitisation to Aspergillus fumigatus is linked to worse outcomes in patients with chronic obstructive pulmonary disease (COPD), however, its prevalence and clinical implications in domestic (residential) settings remains unknown. Methods Individuals with COPD (n=43) recruited in Singapore had their residences prospectively sampled and assessed by shotgun metagenomic sequencing including indoor air, outdoor air, and touch surfaces (total: 126 specimens). The abundance of environmental A. fumigatus and the occurrence of A. fumigatus (Asp f) allergens in the environment were determined and immunological responses to A. fumigatus allergens determined in association with clinical outcomes including exacerbation frequency. Findings were validated in 12 individuals (31 specimens) with COPD in Vancouver, Canada, a climatically different region. Results 157 metagenomes from 43 homes were assessed. Eleven and nine separate Aspergillus spp. were identified in Singapore and Vancouver respectively. Despite climatic, temperature, and humidity variation, A. fumigatus was detectable in the environment from both locations. The relative abundance of environmental A. fumigatus was significantly associated with exacerbation frequency in both Singapore (r=0.27, p=0.003) and Vancouver (r=0.49, p=0.01) and individuals with higher Asp f 3 sensitisation responses lived in homes with a greater abundance of environmental Asp f 3 allergens (p=0.037). Patients exposed and sensitised to Asp f 3 allergens demonstrated a higher rate of COPD exacerbations at 1-year follow-up (p=0.021). Conclusion Environmental A. fumigatus exposure in the home environment including air and surfaces with resulting sensitisation carries pathogenic potential in individuals with COPD. Targeting domestic A. fumigatus abundance may reduce COPD exacerbations. Sensitisation to Aspergillus fumigatus is linked to worse outcomes in patients with chronic obstructive pulmonary disease (COPD), however, its prevalence and clinical implications in domestic (residential) settings remains unknown.BACKGROUNDSensitisation to Aspergillus fumigatus is linked to worse outcomes in patients with chronic obstructive pulmonary disease (COPD), however, its prevalence and clinical implications in domestic (residential) settings remains unknown.Individuals with COPD (n=43) recruited in Singapore had their residences prospectively sampled and assessed by shotgun metagenomic sequencing including indoor air, outdoor air, and touch surfaces (total: 126 specimens). The abundance of environmental A. fumigatus and the occurrence of A. fumigatus (Asp f) allergens in the environment were determined and immunological responses to A. fumigatus allergens determined in association with clinical outcomes including exacerbation frequency. Findings were validated in 12 individuals (31 specimens) with COPD in Vancouver, Canada, a climatically different region.METHODSIndividuals with COPD (n=43) recruited in Singapore had their residences prospectively sampled and assessed by shotgun metagenomic sequencing including indoor air, outdoor air, and touch surfaces (total: 126 specimens). The abundance of environmental A. fumigatus and the occurrence of A. fumigatus (Asp f) allergens in the environment were determined and immunological responses to A. fumigatus allergens determined in association with clinical outcomes including exacerbation frequency. Findings were validated in 12 individuals (31 specimens) with COPD in Vancouver, Canada, a climatically different region.157 metagenomes from 43 homes were assessed. Eleven and nine separate Aspergillus spp. were identified in Singapore and Vancouver respectively. Despite climatic, temperature, and humidity variation, A. fumigatus was detectable in the environment from both locations. The relative abundance of environmental A. fumigatus was significantly associated with exacerbation frequency in both Singapore (r=0.27, p=0.003) and Vancouver (r=0.49, p=0.01) and individuals with higher Asp f 3 sensitisation responses lived in homes with a greater abundance of environmental Asp f 3 allergens (p=0.037). Patients exposed and sensitised to Asp f 3 allergens demonstrated a higher rate of COPD exacerbations at 1-year follow-up (p=0.021).RESULTS157 metagenomes from 43 homes were assessed. Eleven and nine separate Aspergillus spp. were identified in Singapore and Vancouver respectively. Despite climatic, temperature, and humidity variation, A. fumigatus was detectable in the environment from both locations. The relative abundance of environmental A. fumigatus was significantly associated with exacerbation frequency in both Singapore (r=0.27, p=0.003) and Vancouver (r=0.49, p=0.01) and individuals with higher Asp f 3 sensitisation responses lived in homes with a greater abundance of environmental Asp f 3 allergens (p=0.037). Patients exposed and sensitised to Asp f 3 allergens demonstrated a higher rate of COPD exacerbations at 1-year follow-up (p=0.021).Environmental A. fumigatus exposure in the home environment including air and surfaces with resulting sensitisation carries pathogenic potential in individuals with COPD. Targeting domestic A. fumigatus abundance may reduce COPD exacerbations.CONCLUSIONEnvironmental A. fumigatus exposure in the home environment including air and surfaces with resulting sensitisation carries pathogenic potential in individuals with COPD. Targeting domestic A. fumigatus abundance may reduce COPD exacerbations. Sensitisation to is linked to worse outcomes in patients with chronic obstructive pulmonary disease (COPD), however, its prevalence and clinical implications in domestic (residential) settings remains unknown. Individuals with COPD (n=43) recruited in Singapore had their residences prospectively sampled and assessed by shotgun metagenomic sequencing including indoor air, outdoor air, and touch surfaces (total: 126 specimens). The abundance of environmental and the occurrence of (Asp f) allergens in the environment were determined and immunological responses to allergens determined in association with clinical outcomes including exacerbation frequency. Findings were validated in 12 individuals (31 specimens) with COPD in Vancouver, Canada, a climatically different region. 157 metagenomes from 43 homes were assessed. Eleven and nine separate were identified in Singapore and Vancouver respectively. Despite climatic, temperature, and humidity variation, was detectable in the environment from both locations. The relative abundance of environmental was significantly associated with exacerbation frequency in both Singapore (r=0.27, p=0.003) and Vancouver (r=0.49, p=0.01) and individuals with higher Asp f 3 sensitisation responses lived in homes with a greater abundance of environmental Asp f 3 allergens (p=0.037). Patients exposed and sensitised to Asp f 3 allergens demonstrated a higher rate of COPD exacerbations at 1-year follow-up (p=0.021). Environmental exposure in the home environment including air and surfaces with resulting sensitisation carries pathogenic potential in individuals with COPD. Targeting domestic abundance may reduce COPD exacerbations. |
Author | Leung, Janice M Yuen, Agnes Che Yan Dacanay, Justine G Yang, Julia Chandrasekaran, Lakshmi Lim, Yee Hui Drautz-Moses, Daniela I Koh, Mariko Siyue Ivan, Fransiskus Xaverius Johal, Parteek Jaggi, Tavleen Kaur Abisheganaden, John A Schuster, Stephan C Wong, Anthony Chew, Fook Tim Tiew, Pei Yee Carlsten, Christopher Afshar, Tina Tee, Augustine Ong, Thun How Chotirmall, Sanjay H Mac Aogáin, Micheál |
Author_xml | – sequence: 1 givenname: Pei Yee surname: Tiew fullname: Tiew, Pei Yee organization: Joint-first authors – sequence: 2 givenname: Janice M surname: Leung fullname: Leung, Janice M organization: Joint-first authors – sequence: 3 givenname: Micheál surname: Mac Aogáin fullname: Mac Aogáin, Micheál organization: School of Medicine, Trinity College Dublin, Dublin, Ireland – sequence: 4 givenname: Parteek surname: Johal fullname: Johal, Parteek organization: Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, Canada – sequence: 5 givenname: Tavleen Kaur surname: Jaggi fullname: Jaggi, Tavleen Kaur organization: Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore – sequence: 6 givenname: Agnes Che Yan surname: Yuen fullname: Yuen, Agnes Che Yan organization: Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, Canada – sequence: 7 givenname: Fransiskus Xaverius surname: Ivan fullname: Ivan, Fransiskus Xaverius organization: Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore – sequence: 8 givenname: Julia surname: Yang fullname: Yang, Julia organization: Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, Canada – sequence: 9 givenname: Tina surname: Afshar fullname: Afshar, Tina organization: Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, Canada – sequence: 10 givenname: Augustine surname: Tee fullname: Tee, Augustine organization: Department of Respiratory and Critical Care Medicine, Changi General Hospital, Singapore – sequence: 11 givenname: Mariko Siyue orcidid: 0000-0002-1230-0129 surname: Koh fullname: Koh, Mariko Siyue organization: Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore – sequence: 12 givenname: Yee Hui surname: Lim fullname: Lim, Yee Hui organization: Singapore Centre for Environmental Life Sciences Engineering (SCELSE), Nanyang Technological University Singapore – sequence: 13 givenname: Anthony surname: Wong fullname: Wong, Anthony organization: Singapore Centre for Environmental Life Sciences Engineering (SCELSE), Nanyang Technological University Singapore – sequence: 14 givenname: Lakshmi surname: Chandrasekaran fullname: Chandrasekaran, Lakshmi organization: Singapore Centre for Environmental Life Sciences Engineering (SCELSE), Nanyang Technological University Singapore – sequence: 15 givenname: Justine G surname: Dacanay fullname: Dacanay, Justine G organization: Singapore Centre for Environmental Life Sciences Engineering (SCELSE), Nanyang Technological University Singapore – sequence: 16 givenname: Daniela I surname: Drautz-Moses fullname: Drautz-Moses, Daniela I organization: Singapore Centre for Environmental Life Sciences Engineering (SCELSE), Nanyang Technological University Singapore – sequence: 17 givenname: Thun How surname: Ong fullname: Ong, Thun How organization: Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore – sequence: 18 givenname: John A surname: Abisheganaden fullname: Abisheganaden, John A organization: Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore – sequence: 19 givenname: Fook Tim orcidid: 0000-0003-1337-5146 surname: Chew fullname: Chew, Fook Tim organization: Department of Biological Sciences, National University of Singapore, Singapore – sequence: 20 givenname: Stephan C surname: Schuster fullname: Schuster, Stephan C organization: Singapore Centre for Environmental Life Sciences Engineering (SCELSE), Nanyang Technological University Singapore – sequence: 21 givenname: Christopher orcidid: 0000-0003-2455-6575 surname: Carlsten fullname: Carlsten, Christopher organization: Joint-senior authors – sequence: 22 givenname: Sanjay H orcidid: 0000-0003-0417-7607 surname: Chotirmall fullname: Chotirmall, Sanjay H email: schotirmall@ntu.edu.sg organization: Joint-senior authors |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39362665$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kNtKw0AQhhep2IM-gSB76U3qHrrZ7GWpRyhURa_DZjPRlTQbMwnq25vYVuZi4OP_Z-CbklEVKiDknLM554m84tIYyZicM2aYjgQTiyMyGWg04BGZ9FxG3Mh4TKaIH4zxeCH5CRnLnok4VhPy9Azoc6hab0sK33XArgHaBrrEGpo3X5YdUqzrOfVILWJw3raQ0y_fvvd566DJbOtDhdRXdLV5vD4lx4UtEc72e0Zeb29eVvfRenP3sFquI8cZU5FLtHCF0DxLpHAMjJWOaRAuEzrmiSmUWqg8MywrjMq1Aq1NwaXlLC4Skzg5I5e7u3UTPjvANt16dFCWtoLQYSo5F4nqR_dRuYu6JiA2UKR147e2-Uk5SweX6cFl-ucyHVz2rYv9gy7bQv7fOciTvxWvb9o |
ContentType | Journal Article |
Copyright | Copyright ©The authors 2024. For reproduction rights and permissions contact permissions@ersnet.org. |
Copyright_xml | – notice: Copyright ©The authors 2024. For reproduction rights and permissions contact permissions@ersnet.org. |
DBID | NPM AAYXX CITATION 7X8 |
DOI | 10.1183/13993003.00907-2024 |
DatabaseName | PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1399-3003 |
ExternalDocumentID | 10_1183_13993003_00907_2024 39362665 |
Genre | Journal Article |
GroupedDBID | --- .55 18M 1OC 53G 5GY 5RE AADJU AAFWJ ABCQX ABOCM ABSQV ACEMG ACGFO ACPRK ADBBV ADDZX AENEX AFHIN AIZTS ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CS3 E3Z EBS EJD F5P F9R GX1 INIJC KQ8 L7B NPM OK1 P2P PQQKQ R0Z RHF RHI TER TR2 WOQ X7M ~02 AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c1005-c872cf271b832c0e9a3c07e2cb276189f5545db90bf95d75e779f13a106f898c3 |
ISSN | 0903-1936 1399-3003 |
IngestDate | Tue Oct 15 21:44:18 EDT 2024 Wed Oct 23 14:24:10 EDT 2024 Sat Nov 02 12:28:09 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | Copyright ©The authors 2024. For reproduction rights and permissions contact permissions@ersnet.org. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1005-c872cf271b832c0e9a3c07e2cb276189f5545db90bf95d75e779f13a106f898c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-1337-5146 0000-0003-0417-7607 0000-0003-2455-6575 0000-0002-1230-0129 |
PMID | 39362665 |
PQID | 3112858587 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_3112858587 crossref_primary_10_1183_13993003_00907_2024 pubmed_primary_39362665 |
PublicationCentury | 2000 |
PublicationDate | 2024-Oct-10 |
PublicationDateYYYYMMDD | 2024-10-10 |
PublicationDate_xml | – month: 10 year: 2024 text: 2024-Oct-10 day: 10 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | The European respiratory journal |
PublicationTitleAlternate | Eur Respir J |
PublicationYear | 2024 |
SSID | ssj0016431 |
Score | 2.4992933 |
Snippet | Sensitisation to
is linked to worse outcomes in patients with chronic obstructive pulmonary disease (COPD), however, its prevalence and clinical implications... Background Sensitisation to Aspergillus fumigatus is linked to worse outcomes in patients with chronic obstructive pulmonary disease (COPD), however, its... Sensitisation to Aspergillus fumigatus is linked to worse outcomes in patients with chronic obstructive pulmonary disease (COPD), however, its prevalence and... |
SourceID | proquest crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 2400907 |
Title | Residential exposure to Aspergillus spp. is associated with exacerbations in COPD |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39362665 https://www.proquest.com/docview/3112858587 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdbB2Mvo_vO1hUN9pY587esx1BaSkhbOhLInoQsy61HsUPjsLK_fneW_FHaQrcXY4Qjhbufz7_Tne4I-ZolSrupZk6oWOSEUkpH8jADVwU-CFj_jId4GvnkND5ehrNVtGpb3NvTJXU6UX_uPVfyP1qFMdArnpL9B812k8IA3IN-4QoahuujdPxDY7PNssZdb32zrnC3D8nkFMt_XxRXV9vNeLNeT7BrubR6aNPN9Y1UINI-l_zgzLZK_9UDqNurvx5E5Id_rUng1b9Npm8x_qk7nMy1NSMzWRZoPAZ73-NpddFE6L2iy93XZqCbdlZdStNeGbNObUlhuz3hh2jXbaKqsajAgJzAdY0V03fH7trwBGtJ4DP4yARIoMscnLr_ZLVh-tMzcbScz8XicLV4Sp75WOwPA_PnfSQJGJdxuu2StvIULPL9niVus5MHXI6Geix2yUvrM9CpAcAr8kSXr8nzE5sV8YacD3BAWxzQuqIDHFDEAS02tMcBRRzQWzigRUkRB2_J8uhwcXDs2FYZjvKwlqxKmK9yn3kpWGjlai4D5TLtq9RnsZfwHFhjlKXcTXMeZSzSjPHcC6TnxnnCExW8IztlVeoPhOY8lhl3dcgyeFvjGCi6SlkWZZyHXPnRiHxrRSTWpiKKaDzJJBCtREUjUYESHZEvrRgFWC4MR8lSV9uNCIDqY1Q6YSPy3si3mzDgWCYpjj4-4tefyIseeHtkp77e6s_AFOt0v4HCXyvOYyg |
link.rule.ids | 315,783,787,27937,27938 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Residential+exposure+to+Aspergillus+spp.+is+associated+with+exacerbations+in+COPD&rft.jtitle=The+European+respiratory+journal&rft.au=Tiew%2C+Pei+Yee&rft.au=Leung%2C+Janice+M&rft.au=Mac+Aog%C3%A1in%2C+Miche%C3%A1l&rft.au=Johal%2C+Parteek&rft.date=2024-10-10&rft.issn=1399-3003&rft.eissn=1399-3003&rft_id=info:doi/10.1183%2F13993003.00907-2024&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0903-1936&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0903-1936&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0903-1936&client=summon |